arrow
D

Daniela Manno

University of Brescia
H指数:22
被引数:2,500

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo

刚果民主共和国暴发期间孕妇和非孕妇两剂预防性埃博拉病毒疾病疫苗的分娩和安全性

2024-07-231
OAAI
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study
2024-02-172
OAAI
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active- controlled trial in Guinea and Sierra Leone
2023-11-015
OAAI
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

先前暴露于疟疾感染和临床疟疾发作对两剂Ad26.ZEBOV,mva-bn-filo埃博拉疫苗方案的免疫反应的影响

2023-08-020
OAAI
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
2023-03-0112
OAAI
Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children
2022-05-305
OAAI
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
2022-03-013
OAAI
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2022-01-0157
OAAI
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2022-01-0155
OAAI
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

Ad26.ZEBOV和mva-bn-filo埃博拉疫苗的2剂量异源疫苗接种方案的安全性和免疫原性: 来自乌干达和坦桑尼亚的1期随机临床试验的12个月数据

2019-02-23117
OAAI